Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Arlene D Parsons"'
Autor:
Arya Sobhakumari, Laurie Love-Homan, Elise V M Fletcher, Sean M Martin, Arlene D Parsons, Douglas R Spitz, C Michael Knudson, Andrean L Simons
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e48175 (2012)
Increased glutathione (GSH) and thioredoxin (Trx) metabolism are mechanisms that are widely implicated in resistance of cancer cells to chemotherapy. The current study determined if simultaneous inhibition of GSH and Trx metabolism enhanced cell kill
Externí odkaz:
https://doaj.org/article/9c3f6038b8924659b32b069d7c274fdd
Autor:
Erin N. McMullen, Payam Katebi Kashi, Arlene D. Parsons, Katherine L. Dengler, Rhiana D. Saunders
Publikováno v:
Journal of gynecology obstetrics and human reproduction. 50(6)
Background Uterine leiomyoma are implicated in certain adverse pregnancy related outcomes such as postpartum hemorrhage. Large submucosal leiomyoma defined as greater than 5 cm, may have higher complication rates; however, high quality data is limite
Autor:
Laurie Love-Homan, C. Michael Knudson, Kevin P. Orcutt, Arlene D. Parsons, Arya Sobhakumari, Andrean L. Simons, Christopher E. Kowalski
Publikováno v:
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 24:55-64
Poor tumor response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is a significant challenge for effective treatment of head and neck squamous cell carcinoma (HNSCC). Therefore, strategies that may increase tumor respon
Autor:
Prabhat C. Goswami, Yueming Zhu, Andrean L. Simons, Zita A. Sibenaller, Francis J. Miller, Kevin P. Orcutt, Peter M. Scarbrough, Arya Sobhakumari, Werner W. Wilke, Douglas R. Spitz, Amanda L. Kalen, Arlene D. Parsons
Publikováno v:
Cancer Research. 71:3932-3940
Redox regulation of epidermal growth factor receptor (EGFR) signaling helps protect cells against oxidative stress. In this study, we investigated whether the cytotoxicity of an EGFR tyrosine kinase inhibitor, erlotinib (ERL), was mediated by inducti
Autor:
C. Michael Knudson, Arya Sobhakumari, Elise V.M. Fletcher, Douglas R. Spitz, Andrean L. Simons, Laurie Love-Homan, Sean M. Martin, Arlene D. Parsons
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e48175 (2012)
PLoS ONE
PLoS ONE
Increased glutathione (GSH) and thioredoxin (Trx) metabolism are mechanisms that are widely implicated in resistance of cancer cells to chemotherapy. The current study determined if simultaneous inhibition of GSH and Trx metabolism enhanced cell kill
Autor:
Arlene D. Parsons, Kevin P. Orcutt, Andrean L. Simons, Douglas R. Spitz, Melissa A. Fath, Katherine A. Foster
Publikováno v:
Journal of Oncology, Vol 2009 (2009)
Journal of Oncology
Journal of Oncology
The hypothesis that the Akt inhibitor, perifosine (PER), combined with inhibitors of glutathione (GSH) and thioredoxin (Trx) metabolism will induce cytotoxicity via metabolic oxidative stress in human head and neck cancer (HNSCC) cells was tested. PE
Autor:
Peter M. Scarbrough, Francis J. Miller, Douglas R. Spitz, Yueming Zhu, Werner W. Wilke, Arya Sobhakumari, Kevin P. Orcutt, Arlene D. Parsons, Zita A. Sibenaller, Prabhat C. Goswami, Andrean L. Simons, Amanda L. Kalen
Publikováno v:
Free Radical Biology and Medicine. 49:S102-S103
Autor:
Arlene D. Parsons, Arya Sobhakumari, Michael L. McCormick, Andrean L. Simons, Douglas R. Spitz
Publikováno v:
Free Radical Biology and Medicine. 49:S71